Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
Hong Kong · Delayed Price · Currency is HKD 97.55
+1.25 (1.30%)
Sep 10, 2025, 1:44 PM HKT
HKG:6821 Market Cap
HKG:6821 has a market cap or net worth of 41.25 billion as of September 9, 2025. Its market cap has increased by 58.63% in one year.
Market Cap
41.25B
Enterprise Value
33.00B
Revenue
6.90B
Ranking
n/a
PE Ratio
35.27
Stock Price
97.55
Market Cap Chart
Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 41.25B, an increase of 637.91%. That is a compound annual growth rate of 25.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 41.25B | 47.75% |
| Dec 31, 2024 | 27.92B | -38.76% |
| Dec 29, 2023 | 45.59B | -23.48% |
| Dec 30, 2022 | 59.58B | -56.36% |
| Dec 31, 2021 | 136.53B | 58.47% |
| Dec 31, 2020 | 86.15B | 157.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 224.72B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 159.35B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |